Esperion Therapeutics, Inc. (ESPR)
3.775
-0.14
(-3.45%)
USD |
NASDAQ |
Dec 09, 16:00
3.80
+0.02
(+0.66%)
After-Hours: 20:00
Esperion Therapeutics Total Assets (Quarterly): 364.02M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Johnson & Johnson | 192.82B |
| Ovid Therapeutics, Inc. | 63.85M |
| NovaBay Pharmaceuticals, Inc. | 3.487M |
| Palatin Technologies, Inc. | 8.615M |
| Theriva Biologics, Inc. | 30.84M |
Total Assets (Quarterly) Related Metrics
| Shareholders Equity (Quarterly) | -451.36M |
| Debt to Equity Ratio | -1.324 |
| Current Ratio | 1.147 |
| Net Debt Paydown Yield | -1.51% |